Vienna, Austria

ESTRO 2025

Session

Sunday
May 04
15:15 - 16:30
Plenary Hall
Breast cancer in young patients
Fran Duane, Ireland;
Ivica Ratosa, Slovenia
This session will address how carrying BRCA mutations may effect reproductive potential, fertility preservation strategies, and the safety of pregnancy. It will address risk reducing surgery and delve into how loco-regional therapy for those diagnosed with breast cancer may be individualised. Factors influencing surgery and the benefits and risks of breast conservation versus mastectomy will be presented taking into account oncological outcomes, genetic risk factors and patient preferences. Decision-making around adjuvant radiotherapy will be discussed including how novel systemic therapies may modify the radiotherapy landscape. Importantly this symposium will include the patient voice to better understand what is most important to young BRCA carriers in terms of treatment goals and unmet needs.
Symposium
Clinical
Breast
15:15 - 15:33
Reproductive issues in young BRCA carriers affected by breast cancer
Matteo Lambertini, Italy
E25-4763
15:33 - 15:51
Breast-conserving therapy or mastectomy among patients with or without the BRCA1/2 variant: The breast surgeon point of view
Isabel Rubio, Spain
E25-4762
15:51 - 16:09
The impact of BRCA-carriership on indications for RT
Icro Meattini, Italy
E25-4765
16:09 - 16:27
Breast cancer in younger patients: The patient voice
Tanja Spanic, Slovenia
E25-4764
16:27 - 16:30
Presentation of the ESTRO Honorary Member Award to Isabel T. Rubio
Anna Kirby, United Kingdom